Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9M60
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,540
Award facts
- Contract value 100% obligated
- $13,540.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,540.40 to AmerisourceBergen Drug Corp for Wegovy (semaglutide) 1.7 mg/0.75 mL pen injections on December 8, 2025, with a completion date of December 9, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement with no set-aside designation. The award was fulfilled through AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Wegovy, a glucagon-like peptide-1 receptor agonist used for weight management, reflects the company's role in supplying specialized pharmaceutical products to support military and veteran healthcare needs through DLA's procurement channels.
Quick answers
Who was awarded contract SPE2DR26F9M60?
SPE2DR26F9M60 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F9M60 worth?
The government has obligated $13,540 on SPE2DR26F9M60.
Is contract SPE2DR26F9M60 an order under another contract?
Yes. SPE2DR26F9M60 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9M60 competed?
The extent of competition for SPE2DR26F9M60 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award